PG

P&G’s moat remains its unmatched brand portfolio and scale in household and personal care, which supports premium pricing, wide distribution, and heavy advertising/innovation spend. Q3 FY2026 results show the model is still resilient: net sales were $21.2B (+7% y/y) with organic sales up about 3%, suggesting demand is holding despite a tougher consumer and channel mix. New premium launches and brand partnerships can help defend share, but the category is increasingly competitive with private label and value tiers.

Financially, profitability remains strong for a staples name: FY2025 net sales were $84.3B and net earnings attributable to P&G were about $16.0B, with diluted EPS $6.51 and core EPS $6.83. Q3 FY2026 GAAP EPS was $1.63 and core EPS $1.59, and management maintained FY2026 guidance for 0%–4% organic sales growth and 0%–4% core EPS growth, implying a steady but not accelerating earnings profile. Income investors still get paid: the quarterly dividend is about $1.089 (roughly $4.36 annualized), but valuation looks full for low-single-digit growth given the 52-week high near $171.65.

Over the next 12 months, the thesis is “defensive compounder”: modest organic growth plus dividends, supported by pricing power and productivity programs, should deliver mid-single-digit total returns if the multiple holds. Key catalysts are sustained volume stabilization, easing input cost/tariff pressure, and clearer upside to FY2026 guidance; key risks are renewed margin compression from promotions, FX, and private-label trade-down. With the stock having recently traded around the high-$140s to low-$150s, upside likely depends more on execution than rerating.

Recommendation: HOLD. P&G offers high business quality and reliable cash returns, but the current growth outlook and likely premium valuation limit 12-month upside unless margins expand or volumes reaccelerate.